HEOR Theater - HTA Implementation in the MEA Region – an Overview From WHO and Country Updates

February 23, 2023

Open to all ISPOR Members and Non-members

Title: HTA Implementation in the MEA Region – an Overview From WHO and Country Updates

    Thursday, February 23, 2023
    10:00AM EST | 3:00PM UTC | 4:00PM CET

    Click here for time zone conversion

    Register Now



    On 4 October 2022, ISPOR held the Health Technology Assessment (HTA) Roundtable for the Middle East and Africa (MEA) Region. During this meeting, the World Health Organization (WHO) presented the findings of their Health Technology Assessment and Health Benefit Package Survey 2020/2021 as well as their document Institutionalizing Health Technology Assessment Mechanisms: a How to Guide. Participants of the roundtable then reflected on the survey results and discussed the situation surrounding HTA institutionalization in their country.


    In this HEOR Theater presentation, we will replicate the conversations that were held during the roundtable. First a short presentation will be provided by the WHO on the 2021 survey results and institutionalizing HTA how to document. Three participants from countries in the MEA region will then be asked to provide a short reflection on the document and the status of HTA in their country. The session will finish with a short Q&A from the audience.

    The goal of the ISPOR HTA Roundtables is to discuss only among HTA bodies, public and private payers, other governmental decision makers, and academics when no HTA body exists in the country, the application of research on health technologies and to promote a valuable exchange of information, methods, and knowledge in the development of value assessment, or health technology assessment, in 5 major regions of the world (Asia Pacific, Europe, Latin America, Middle East and Africa, and North America). Additional information on the ISPOR HTA Roundtables are available here.

    Learning Objectives

    • Be informed about the update to the WHO HTA and Benefits Package Survey
    • Learn from different countries in the region about the status of HTA in their country
    • Receive information about best practices in institutionalizing HTA


    Jessica Daw, PharmD, MBA, Vice President, Sentara Health Plans, Virginia Beach, VA, USA


    Andrew Mirelman, PhD, MPH, Technical Officer, Department of Health Financing and Governance (HGF), World Health Organization, Geneva, Switzerland

    Stella Matutina Umuhoza, MSc, Consultant and Health Financing Expert, Ministry of Health, Kigali, Rwanda

    Mary Roushdy Kirolos, PhD, MSc, Head, Central Administration of Health Technology, The Egyptian Authority for Unified Procurement (UPA), Cairo, Egypt

    William Reuben, Pharmaceutical Services Unit, Community Development, Gender, Elderly and Children, Ministry of Health, Dar es Salaam, Tanzania

    Please note: On the day of the scheduled HEOR Theater, the first 1000 registered participants will be accepted. For those who are unable to attend, or would like to review the HEOR Theater On-Demand at a later date, please register using the link above to access the full-length recording. 

    Reservations are on a first-come, first-served basis.

    Your browser is out-of-date

    ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now